Anaphylaxis Treatment Market Report for M&A, Expansion and Competitive Benchmarking (2025–2034)

 We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

 
 What is the anticipated market size of the anaphylaxis treatment industry over the next few years?
 The anaphylaxis treatment market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.61 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing incidence of allergic reactions, wider recognition of anaphylaxis, increased availability of epinephrine auto-injectors, public awareness and education, healthcare professional training
 
 The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $8.72 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to innovation in biologic therapies, customized treatment approaches, global efforts on food safety, patient empowerment and advocacy, enhanced emergency medical services. Major trends in the forecast period include auto-injectors innovation, telemedicine for anaphylaxis management, improved allergen immunotherapy, biometric wearables for allergen detection, collaborations in allergy research.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp
 
 What emerging drivers are expected to shape the future of the anaphylaxis treatment market?
 The rise in the prevalence of food allergies is expected to propel the growth of the anaphylaxis treatment market going forward. Food allergy refers to an immune reaction to proteins in food. Anaphylaxis treatment helps to prevent the progression of life-threatening allergic symptoms involving the skin, mucosal surface, respiratory compromise, hypotension, and end-organ dysfunction. For instance, in January 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, 31.8% of adults aged 18 and older reported having eczema, a seasonal allergy, or a food allergy. One-fourth (25.7%) of adults had a seasonal allergy, 6.2% had a food allergy, and 7.3% of individuals had eczema. Additionally, in August 2024, according to the Food Standards Agency, a UK-based non-ministerial department, a total of 296 valid case reports were submitted to the Registry between October 2021 and August 27, 2023, likely reflecting less than 5% of accidental reactions in the UK, with 213 (72%) of these reports attributed to food triggers and 208 (97.7%) occurring in children and young people aged 18 or younger, while only 28 clinics and 11 Accident & Emergency (A&E) departments registered for access to the platform. Therefore, the rise in the prevalence of food allergies is driving the growth of the anaphylaxis treatment market.
 
 What emerging segments are shaping the future landscape of the anaphylaxis treatment industry?
 The anaphylaxis treatment market covered in this report is segmented –
 
 1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
 2) By Product: Tablets, Capsules, Other Products
 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
 4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
 
 Subsegments:
 1) By Epinephrine: Auto-Injectors, Vials Or Syringes
 2) By Antihistamines: Oral Antihistamines, Injectable Antihistamines
 3) By Steroids: Oral Steroids, Injectable Steroids
 4) By Beta-antagonists: Oral Beta-blockers, Injectable Beta-blockers
 5) By Other Treatments: Corticosteroids, Intravenous Fluids, Other Supportive Treatments
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
 
 What are the key trends shaping the anaphylaxis treatment market in the forecast period?
 Advancement in product development is a key trend gaining popularity in the anaphylaxis treatment market. Major companies operating in the anaphylaxis treatment market are advancing their products to sustain their position in the market. For instance, in April 2022, Aquestive Therapeutics Inc., a US-based pharmaceutical company, received Fast Track designation for AQST-109 for the treatment of severe allergic responses, including anaphylaxis, from the Food and Drug Administration. Aquestive is moving forward with the clinical testing of AQST-109, the first and only orally administered epinephrine product candidate that has demonstrated clinical outcomes equivalent to autoinjectors (such as EpiPen and Auvi-Q) for the treatment of allergic emergencies, including anaphylaxis.
 
 How are key players in the anaphylaxis treatment market strengthening their market position?
 Major companies operating in the anaphylaxis treatment market include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, Impax Laboratories LLC
 
 Which geographic areas are contributing significantly to the growth of the anaphylaxis treatment sector?
 North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Anaphylaxis Treatment Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12105
 
 Need Customized Data On Anaphylaxis Treatment Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=12105&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company